These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20649937)

  • 1. Semliki Forest virus-mediated gene therapy of the RG2 rat glioma.
    Roche FP; Sheahan BJ; O'Mara SM; Atkins GJ
    Neuropathol Appl Neurobiol; 2010 Dec; 36(7):648-60. PubMed ID: 20649937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.
    Määttä AM; Liimatainen T; Wahlfors T; Wirth T; Vähä-Koskela M; Jansson L; Valonen P; Häkkinen K; Rautsi O; Pellinen R; Mäkinen K; Hakumäki J; Hinkkanen A; Wahlfors J
    Int J Cancer; 2007 Aug; 121(4):863-70. PubMed ID: 17443493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.
    Yamanaka R; Zullo SA; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG
    Neurosurg Focus; 2000 Dec; 9(6):e7. PubMed ID: 16817690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
    Yamanaka R; Zullo SA; Ramsey J; Yajima N; Tsuchiya N; Tanaka R; Blaese M; Xanthopoulos KG
    J Neurosurg; 2002 Sep; 97(3):611-8. PubMed ID: 12296646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
    Chen B; Timiryasova TM; Andres ML; Kajioka EH; Dutta-Roy R; Gridley DS; Fodor I
    Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.
    Okada H; Villa L; Attanucci J; Erff M; Fellows WK; Lotze MT; Pollack IF; Chambers WH
    Gene Ther; 2001 Aug; 8(15):1157-66. PubMed ID: 11509946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and delivery methods for the linamarase/linamarin/glucose oxidase system, when used against human glioma tumors implanted in the brain of nude rats.
    Girald W; Collin A; Izquierdo M
    Cancer Lett; 2011 Dec; 313(1):99-107. PubMed ID: 21955616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12.
    Chikkanna-Gowda CP; Sheahan BJ; Fleeton MN; Atkins GJ
    Gene Ther; 2005 Aug; 12(16):1253-63. PubMed ID: 15944731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ; Trask TW; Chen SH; Goodman JC; Woo SL; Grossman RG; Shine HD
    J Neurosci Res; 1994 Nov; 39(4):506-11. PubMed ID: 7884826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
    Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
    Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
    Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
    Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.
    Rodriguez-Madoz JR; Prieto J; Smerdou C
    Mol Ther; 2005 Jul; 12(1):153-63. PubMed ID: 15963931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells.
    Zhang J; Asselin-Paturel C; Bex F; Bernard J; Chehimi J; Willems F; Caignard A; Berglund P; Liljeström P; Burny A; Chouaib S
    Gene Ther; 1997 Apr; 4(4):367-74. PubMed ID: 9176524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus vector in glioblastoma cells.
    Lee JS; Lee JH; Poo H; Kim MS; Lee SH; Sung MH; Kim CJ
    Int J Oncol; 2006 Mar; 28(3):649-54. PubMed ID: 16465369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy.
    Zhu J; Zhang L; Hanisch UK; Felgner PL; Reszka R
    Gene Ther; 1996 Jun; 3(6):472-6. PubMed ID: 8789795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.